Centrally Acting ACE Inhibition in SLE

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

June 3, 2025

Study Completion Date

March 1, 2026

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Lisinopril Pills

Tablets will be taken by oral administration daily, based on titration

DRUG

Benazepril Pill

Tablets will be taken by oral administration daily, based on titration

Trial Locations (7)

10016

New York University School of Medicine, New York

10032

Columbia University Medical Center, New York

10461

Albert Einstein College of Medicine, The Bronx

11021

Northwell Rheumatology, Great Neck

11030

Andrew Shaw, Manhasset

20021

Hospital for Special Surgery, New York

06519

Yale University School of Medicine, New Haven

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Lupus Research Alliance

OTHER

lead

Northwell Health

OTHER